Posttransplant peripheral blood donor-specific interferon-γ enzyme-linked immune spot assay differentiates risk of subclinical rejection and de novo donor-specific alloantibodies in kidney transplant recipients.

MLA

Crespo, Elena, et al. “Posttransplant Peripheral Blood Donor-Specific Interferon-γ Enzyme-Linked Immune Spot Assay Differentiates Risk of Subclinical Rejection and de Novo Donor-Specific Alloantibodies in Kidney Transplant Recipients.” Kidney International, vol. 92, no. 1, July 2017, pp. 201–13. EBSCOhost, https://doi.org/10.1016/j.kint.2016.12.024.

APA

Crespo, E., Cravedi, P., Martorell, J., Luque, S., Melilli, E., Cruzado, J. M., Jarque, M., Meneghini, M., Manonelles, A., Donadei, C., Lloberas, N., Gomà, M., Grinyó, J. M., Heeger, P., & Bestard, O. (2017). Posttransplant peripheral blood donor-specific interferon-γ enzyme-linked immune spot assay differentiates risk of subclinical rejection and de novo donor-specific alloantibodies in kidney transplant recipients. Kidney International, 92(1), 201–213. https://doi.org/10.1016/j.kint.2016.12.024

Chicago

Crespo, Elena, Paolo Cravedi, Jaume Martorell, Sergi Luque, Edoardo Melilli, Josep M Cruzado, Marta Jarque, et al. 2017. “Posttransplant Peripheral Blood Donor-Specific Interferon-γ Enzyme-Linked Immune Spot Assay Differentiates Risk of Subclinical Rejection and de Novo Donor-Specific Alloantibodies in Kidney Transplant Recipients.” Kidney International 92 (1): 201–13. doi:10.1016/j.kint.2016.12.024.